CARDIAC DISEASE DETERMINATION BY MEASUREMENT OF CONCENTRATION OF 1-beta-D-RIBOFURANOSYL PYRIDINE-4-ON-3-CARBOXAMIDE

PROBLEM TO BE SOLVED: To prevent blood collection from burdening patients and improve the prevention of blood infection of healthcare professionals more than a conventional method by a method for detecting the critical state of cardiac diseases by measuring the concentration of 1-β-D-ribofuranosyl p...

Full description

Saved in:
Bibliographic Details
Main Authors NISHIZAWA MANABU, YAGI SHIGEAKI, MATSUZAWA HIDETOSHI, SHIMIZU KAZUHIRO, ARAKI HIROMASA
Format Patent
LanguageEnglish
Published 04.12.2008
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To prevent blood collection from burdening patients and improve the prevention of blood infection of healthcare professionals more than a conventional method by a method for detecting the critical state of cardiac diseases by measuring the concentration of 1-β-D-ribofuranosyl pyridine-4-on-3-carboxamide in urine (creatinine correction value). SOLUTION: The concentration of 1-β-D-ribofuranosyl pyridine-4-on-3-carboxamide (henceforth, 4,3-PCNR) in urine derived from object mammals is measured and compared with the concentration of 4,3-PCNR derived from a healthy mammal to detect a state in which cardiac diseases have developed or the state of a strong possibility of future development of cardiac diseases in the object mammals. COPYRIGHT: (C)2009,JPO&INPIT
Bibliography:Application Number: JP20070135365